ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

TargetBeta

NECTIN4

nectin cell adhesion molecule 4 · also nectin-4, PRR4, LNIR, PVRL4 · V-set domain containing

10 programs in company-led studies act on NECTIN4, from 10 companies: 3 in phase 3, 1 approved with new studies. Each with where its target was read from.

Programs

Furthest phase first. A target read by rule is marked rule (9 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.

ProgramCompanyActs asFurthest phaseStudiesAlso acts onRead from
enfortumab vedotinruleAstellas Pharma–phase 42010 running–NCIt
notiretatug rezetecanJiangsu HengRui Medicine–phase 31414 running–the company's pipeline
bulumtatug fuvedotinruleMabwell (Shanghai) Bioscience–phase 31313 running–NCIt
Sutantatug EnvedotinruleCSPC Pharmaceutical Group–phase 366 running–NCIt
zelenectide pevedotinruleBicycleTx–phase 255 runningBTCNCIt
Anti-nectin-4 Antibody-drug Conjugate MK-3120ruleMerck–phase 254 running–NCIt
Anti-nectin-4/Anti-TROP2 Bispecific Antibody-drug Conjugate AVZO-103ruleAvenzo Therapeutics–phase 211 runningTACSTD2NCIt
Anti-nectin-4 Antibody-drug Conjugate IPH4502ruleInnate Pharma–phase 111 running–NCIt
Anti-nectin-4/CD28 Bispecific Antibody RNDO-564ruleRondo Therapeutics–phase 111 runningCD28NCIt
CT-202ruleContext Therapeutics–phase 111 running–the studies' text

Primary completions ahead

Each program’s next study to reach its primary completion, by the sponsor’s estimate.

What this can’t show

  • Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
  • A target read by rule can be wrong; each program’s page quotes the words it was read from.
  • “Acts as” is read from the words its target was read from — agonist, antagonist, inhibitor, lowers it (an siRNA or antisense drug), degrader — and is a dash where they do not say, or say two things; an antibody that only “binds” says neither.
  • Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.